Quote:

---

My brain filed away what Dr. BP claimed as leronlimab boosted the immune system which allowed the immune system to kill the virus more efficiently. So leronlimab doesn't directly reduce the viral load, but one with the virus taking leronlimab will see a reduction in viral load faster than someone who doesn't.

---

It's the boosting of the killer CD8+ T cells and those cells kill the virus. The same thing is seen in HIV. I still think there's a good possibility of direct antiviral action through the mTORc1 pathway. The company is more concerned with trial results rather than basic research so that will probably never be explored.